Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Seawater metagenome

ABSTRACT: PLL-SIP Metagenomic assembly

PROVIDER: PRJNA445933 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7062300.fastq.gz	Fastqsanger.gz
	SRR7062310.fastq.gz	Fastqsanger.gz
	SRR7062320.fastq.gz	Fastqsanger.gz
	SRR7062330.fastq.gz	Fastqsanger.gz
	SRR7062340.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 52

Similar Datasets

seawater metagenome

Project description:PLL-SIP

| PRJDB6893 | ENA

PLL-SIP

Project description:PLL-SIP Metagenome

| PRJNA445580 | ENA

PLL-SIP

Project description:PLL-SIP Raw sequence reads

| PRJNA445579 | ENA

seawater metagenome

Project description:seawater metagenome Metagenomic assembly

| PRJNA416907 | ENA

seawater metagenome

Project description:seawater metagenome Metagenomic assembly

| PRJNA321733 | ENA

Metagenome and Viral Interrogation of a Moose Rumen Microbial Community

Project description:Proteomic data from moose fistulated rumen; metagenomic and viral sequencing performed; metabolic pathways reconstructed

2018-07-03 | PXD008667 | Pride

marine metagenome

Project description:May 2013 DNA-SIP marine seawater bacteria metagenomic assembly

| PRJNA297372 | ENA

Next generation sequencing of small non-coding RNAs of T-PLL patients and normal T-cell fractions

Project description:T cell prolymphocytic leukemia (T-PLL) is mostly characterized by aberrant expansion of small to medium sized pro-lymphocytes with a mature post-thymic phenotype, high aggressiveness of the disease and poor prognosis. However, T-PLL is more heterogeneous with a wide-range of clinical, morphological, and molecular features, which occasionally impedes the diagnosis. We hypothesized that T-PLL consists of phenotypic and genotypic subgroups that may explain the heterogeneity of the disease. We found that T-PLL does not show a clear skewing in T cell receptor alpha (TRA), TRB gene usage and CDR3 stereotypy. In addition, multi-dimensional immuno-phenotyping and gene expression profiling did not reveal clear T-PLL subgroups. However, based on miRNA expression profiles, T-PLL samples did clearly cluster in subgroups. We identified 35 miRNAs that were aberrantly expressed in T-PLL with miR-200c/141 as the most differentially expressed cluster. High miR-200c/141 expression was significantly correlated with increased white blood cell counts and poor survival. Furthermore, we found that overexpression of miR-200c/141 in T-PLL correlated with downregulation of their targets ZEB2 and TGFβR3, indicating that the TGFβ pathway is affected. Our results thus highlight the emerging role for aberrantly expressed oncogenic miRNAs in T-PLL, thereby paving the way for new therapeutic targets in this disease.

2021-04-02 | GSE147932 | GEO

High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance

Project description:Sipuleucel-T (sip-T) is the only FDA-approved autologous cellular immunotherapy for metastatic castration-resistant prostate cancer (mCRPC). Here, we report the first high-dimensional analyses of sip-T using mass cytometry (CyTOF) and show a lymphoid predominance, with CD3+ T cells constituting the highest proportion (median ~60%) of sip-T, followed by B-cells, and natural killer (NK) and NKT cells. We hypothesized that treatment of sip-T with homeostatic cytokines known to activate/expand effector lymphocytes could augment efficacy against prostate cancer. Of cytokines tested, IL-15 treated sip-T showed the most significant activation/proliferation of effector lymphocytes in an antigen-specific manner, as well as augmentation of tumor cytotoxicity in-vitro. Adoptive transfer of IL-15 treated sip-T into NSG mice resulted in potent prostate tumor growth inhibition compared with control sip-T. Evaluation of tumor-infiltrating lymphocytes revealed a two-to-fourteen-fold higher influx of sip-T and a significant increase in interferon (IFN)-γ producing CD8+ T and NKT cells within the tumor microenvironment (TME) in the IL-15 group.

2025-01-01 | GSE254296 | GEO

High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance

2025-01-01 | GSE254623 | GEO